FIELD: medicine.
SUBSTANCE: what is used as a hepatoprotector is hyaluronidase immobilised on a low-molecular water-soluble polymer with using an electron-beam synthesis nanotechnology. Using this agent enables both stimulation of regional precursor cells and considerable extension of an elementary cell pool of depot tissue (bone marrow), their mobilisation in peripheral blood and targeted homing into an affected organ.
EFFECT: ensured manifested hepatoprotective effects with underlying lower risk of complications.
3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
AGENT FOR INCREASING RESERVED STEM CELL NUMBER IN ORGANISM | 2009 |
|
RU2405822C1 |
HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
LIFESPAN INCREASING DRUG | 2011 |
|
RU2461389C1 |
MEDICATION FOR REGENERATIVE MEDICINE | 2009 |
|
RU2406528C2 |
HYPOGLYCEMIC AGENT IN NON-INSULIN-DEPENDENT DIABETES MELLITUS | 2009 |
|
RU2416427C1 |
ANTI-INFLAMMATORY AGENT | 2011 |
|
RU2458126C1 |
EXPERIMENTAL TOXIC CHRONIC HEPATITIS TREATMENT METHOD | 2009 |
|
RU2392000C1 |
Authors
Dates
2012-03-10—Published
2010-10-11—Filed